BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7686387)

  • 1. Inhibition of HIV-1 replication in H9 cells by nystatin-A compared with other antiviral agents.
    Selvam MP; Blay RA; Geyer S; Buck SM; Pollock L; Mayner RE; Epstein JS
    AIDS Res Hum Retroviruses; 1993 May; 9(5):475-81. PubMed ID: 7686387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2',3'-dideoxythymidine.
    Kong XB; Zhu QY; Ruprecht RM; Watanabe KA; Zeidler JM; Gold JW; Polsky B; Armstrong D; Chou TC
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2003-11. PubMed ID: 1722077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of HIV infection by baicalin--a flavonoid compound purified from Chinese herbal medicine.
    Li BQ; Fu T; Yan YD; Baylor NW; Ruscetti FW; Kung HF
    Cell Mol Biol Res; 1993; 39(2):119-24. PubMed ID: 7693133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lecithinized superoxide dismutase: an inhibitor of human immunodeficiency virus replication.
    Premanathan M; Nakashima H; Igarashi R; Mizushima Y; Yamada K
    AIDS Res Hum Retroviruses; 1997 Mar; 13(4):283-90. PubMed ID: 9071427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisheteroarylpiperazine reverse transcriptase inhibitor in combination with 3'-azido-3'-deoxythymidine or 2',3'-dideoxycytidine synergistically inhibits human immunodeficiency virus type 1 replication in vitro.
    Chong KT; Pagano PJ; Hinshaw RR
    Antimicrob Agents Chemother; 1994 Feb; 38(2):288-93. PubMed ID: 7514857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral action of oligodeoxyguanylic acids against human immunodeficiency virus type 1.
    Fujihashi T; Sakata T; Kaji A; Kaji H
    AIDS Res Hum Retroviruses; 1995 Apr; 11(4):461-71. PubMed ID: 7543270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-human immunodeficiency virus 1 (HIV-1) activities of 3-deazaadenosine analogs: increased potency against 3'-azido-3'-deoxythymidine-resistant HIV-1 strains.
    Mayers DL; Mikovits JA; Joshi B; Hewlett IK; Estrada JS; Wolfe AD; Garcia GE; Doctor BP; Burke DS; Gordon RK
    Proc Natl Acad Sci U S A; 1995 Jan; 92(1):215-9. PubMed ID: 7816820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of azidothymidine to inhibit human immunodeficiency virus (HIV) replication in a promonocytic cell line (U937).
    Uherová P; Schmidtmayerová H; Mayer V
    Acta Virol; 1991 Aug; 35(4):357-64. PubMed ID: 1724875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New lipophilic alkyl/acyl dinucleoside phosphates as derivatives of 3'-azido-3'-deoxythymidine: inhibition of HIV-1 replication in vitro and antiviral activity against Rauscher leukemia virus infected mice with delayed treatment regimens.
    Schwendener RA; Gowland P; Horber DH; Zahner R; Schertler A; Schott H
    Antiviral Res; 1994 May; 24(1):79-93. PubMed ID: 7944315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic antiviral action of ribonucleotide reductase inhibitors and 3'-azido-3'-deoxythymidine on HIV type 1 infection in vitro.
    Giacca M; Borella S; Calderazzo F; Bianchi LC; D'Agaro P; Rampazzo C; Bianchi V; Reichard P
    AIDS Res Hum Retroviruses; 1996 May; 12(8):677-82. PubMed ID: 8744578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo reverse transcription is a crucial event in cell-to-cell transmission of human immunodeficiency virus.
    Li P; Kuiper LJ; Stephenson AJ; Burrell CJ
    J Gen Virol; 1992 Apr; 73 ( Pt 4)():955-9. PubMed ID: 1378883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse transcriptase (RT)-independent as well as RT-dependent HIV-1 replication exists in syncytia following cell fusion.
    Takami Y; Ito M; Baba M; Ikuta K; Tanabe F; Shigeta S
    Fukushima J Med Sci; 1999 Jun; 45(1):13-24. PubMed ID: 10748552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of HIV replication by adriamycin in macrophages but not in lymphocytes.
    Bergamini A; Perno CF; Balzarini J; Capozzi M; Marinelli L; Milanese G; Pesce CD; Calió R; Rocchi G
    AIDS Res Hum Retroviruses; 1992 Jul; 8(7):1239-47. PubMed ID: 1381599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine.
    García-Lerma JG; MacInnes H; Bennett D; Weinstock H; Heneine W
    J Virol; 2004 Jul; 78(14):7545-52. PubMed ID: 15220429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-human immunodeficiency virus (HIV) activities of halogenated gomisin J derivatives, new nonnucleoside inhibitors of HIV type 1 reverse transcriptase.
    Fujihashi T; Hara H; Sakata T; Mori K; Higuchi H; Tanaka A; Kaji H; Kaji A
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2000-7. PubMed ID: 8540706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human immunodeficiency virus type 1 replication by 7-methyl-6,8-bis(methylthio)pyrrolo[1,2-a]pyrazine, an in vivo metabolite of oltipraz.
    Prochaska HJ; Bornmann WG; Baron P; Polsky B
    Mol Pharmacol; 1995 Jul; 48(1):15-20. PubMed ID: 7542738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribosomal inhibitory proteins from plants inhibit HIV-1 replication in acutely infected peripheral blood mononuclear cells.
    Olson MC; Ramakrishnan S; Anand R
    AIDS Res Hum Retroviruses; 1991 Dec; 7(12):1025-30. PubMed ID: 1725958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility testing by polymerase chain reaction DNA quantitation: a method to measure drug resistance of human immunodeficiency virus type 1 isolates.
    Eron JJ; Gorczyca P; Kaplan JC; D'Aquila RT
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3241-5. PubMed ID: 1565615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of triciribine and triciribine-5'-monophosphate against human immunodeficiency virus types 1 and 2.
    Kucera LS; Iyer NP; Puckett SH; Buckheit RW; Westbrook L; Toyer BR; White EL; Germany-Decker JM; Shannon WM; Chen RC
    AIDS Res Hum Retroviruses; 1993 Apr; 9(4):307-14. PubMed ID: 7685612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporation of 12-methoxydodecanoate into the human immunodeficiency virus 1 gag polyprotein precursor inhibits its proteolytic processing and virus production in a chronically infected human lymphoid cell line.
    Bryant ML; Ratner L; Duronio RJ; Kishore NS; Devadas B; Adams SP; Gordon JI
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2055-9. PubMed ID: 2006142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.